Coronary plaque regression: Role of low density lipoprotein-apheresis

Journal of the American College of Cardiology

Volumn 40, Issue 2, 2002, Pages 228-230

  Barter, Philip J ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; COLESTYRAMINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ANGIOCARDIOGRAPHY; APHERESIS; ARTERY DIAMETER; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; HIGH RISK PATIENT; HUMAN; INTRAVASCULAR ULTRASOUND; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0037125413     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01961-7     Document Type: Editorial

References (15)

1. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease
2. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
4. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
6. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
7. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texs Coronary Atherosclerosis Prevention Study
8. Mortality rates after 1-5 years for participants in the Multiple Risk Factor Intervention Trial
9. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
10. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grants
11. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): A prospective, randomised, double-blind trial
12. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: The Low Density Lipoprotein-Apheresis Coronary Morphology, and Research Trial (LACMART)
13. Long-term efficacy of low density lipoprotein apheresis on coronary heart disease
14. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia
15. Beneficial effects of colestipol-niacin on coronary atherosclerosis: A 4-year follow-up